News – Page 810 – Endpoints News

FDA commissioner Hahn ousts agency’s new chief spokesperson as plasma controversy continues to smolder

5 years ago

Offers upped and upped again, CEO-to-CEO calls and perhaps a veiled walkout threat: Inside Sanofi CEO Paul Hudson's ...

5 years ago

GlaxoSmithKline says it's one step closer to a functional hep B cure — but J&J and other rivals are rushing there

5 years ago

Fortress Biotech takes out $60M loan for debt purposes; Entasis pulls in $25M private placement for PhIII trial

5 years ago

Michael Varney comes out of brief Genentech 'retirement' for R&D gig at Erasca; Vivek Ramaswamy's Immunovant recruits ...

5 years ago

AbbVie and Harvard team up to find new drugs for the next new viruses

5 years ago

Cancer Research UK and NCI to kick off next rounds of Grand Challenges

5 years ago

Covid-19 roundup: J&J launching new PhII vaccine trials in Europe; Abbott scores $760M testing kit order from HHS

5 years ago

Trump promises a safe, effective vaccine for Covid-19 before year’s end — 'or maybe even sooner!' So where does ...

5 years ago

A nano-cap struggles to ride the IPO wave; Seattle Genetics gets a GSK milestone

5 years ago

Another biotech — Seattle-based Athira — files for an IPO, hoping to finally break through in Alzheimer's

5 years ago

Will supply chain demands freeze Pfizer and BioNTech out of a big chunk of the Covid-19 market?

5 years ago

FDA drafts recommendations for studying cancer drugs in patients with CNS metastases

5 years ago

That pipeline AbbVie acquired in the $63B Allergan buyout? It’s not doing so well

5 years ago

Cosmo spinout Cassiopea wins FDA approval for new acne drug

5 years ago

Covid-19 roundup: BeiGene snags rights to potential antibody treatment; Beefing up manufacturing ops, Regeneron adds ...

5 years ago

Triumvira snags $55M Series A to guide TAC technology to the clinic

5 years ago

FDA commish Hahn spotlights Oct 22 vaccine advisory meeting as the next big flashpoint in the Covid-19 campaign

5 years ago

Clene Nanomedicine, researching the use of gold atoms to slow ALS progression, nets $42.5M Series D

5 years ago

Ex-Celgene exec steers his biotech startup to Hong Kong IPO as potential cancer drug launch looms

5 years ago

Tizona completes spinout of cancer program as part of Gilead buyout; Dyne files for $100M IPO

5 years ago

Moderna takes one more step along the high-wire act of Covid-19 vaccine work, offering markers of success for the ...

5 years ago

A Forbion-funded startup bought the rights to Amgen's CETP inhibitor, and is giving the cholesterol drug another go

5 years ago

Synthego adds $100M from RA, Wellington, 8VC in pursuit of 'virtualizing biology'

5 years ago

First page Previous page 807 808 809810811 812 813 Next page Last page